UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024410
Receipt number R000028083
Scientific Title Epidemiological study on incidence, stage at diagnosis, treatment and prognosis of Merkel cell carcinoma in Japan
Date of disclosure of the study information 2016/10/14
Last modified on 2016/10/14 10:57:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Epidemiological study on incidence, stage at diagnosis, treatment and prognosis of Merkel cell carcinoma in Japan

Acronym

Epidemiological study of Merkel cell carcinoma in Japan

Scientific Title

Epidemiological study on incidence, stage at diagnosis, treatment and prognosis of Merkel cell carcinoma in Japan

Scientific Title:Acronym

Epidemiological study of Merkel cell carcinoma in Japan

Region

Japan


Condition

Condition

Merkel cell carcinoma

Classification by specialty

Dermatology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This study is conducted to determine the current status of treatment plan and prognosis of Merkel cell carcinoma in Japan

Basic objectives2

Others

Basic objectives -Others

Epidemiology

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Prognosis of Merkel cell carcinoma

Key secondary outcomes

The number of patients, stage at diagnosis and types of treatments of Merkel cell carcinoma


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients diagnosed with histologically confirmed Merkel cell carcinoma between January, 2005 and December, 2014 in Japan

Key exclusion criteria

None

Target sample size

150


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yutaka Narisawa

Organization

Saga University

Division name

Division of Dermatology, Department of Internal Medicine

Zip code


Address

5-1-1 Nabeshima, Saga, Saga 849-8501, Japan

TEL

0952-34-2368

Email

narisawa@cc.saga-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kotaro Nagase

Organization

Saga University

Division name

Division of Dermatology, Department of Internal Medicine

Zip code


Address

5-1-1 Nabeshima, Saga, Saga 849-8501, Japan

TEL

0952-34-2368

Homepage URL


Email

nagasek@cc.saga-u.ac.jp


Sponsor or person

Institute

Saga University

Institute

Department

Personal name



Funding Source

Organization

Saga University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 10 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2016 Year 09 Month 05 Day

Date of IRB


Anticipated trial start date

2016 Year 09 Month 05 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2016 Year 10 Month 14 Day

Last modified on

2016 Year 10 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028083


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name